Analysis
AI & Data
What CD45RA adds to rare-event counting in AML
Adding CD45RA to the CD34-positive, CD38-negative gate sharpened its association with measurable residual disease in one retrospective cohort. The event denominator and the definition of the gate determine what can be reported.
CFCM Technical Review of a retrospective AML study. DOI 10.1186/s13287-026-05038-w. Editorial synthesis.
Standfirst: Adding CD45RA to the CD34-positive, CD38-negative gate sharpened its association with measurable residual disease in one retrospective cohort. The event denominator and the definition of the gate determine what can be reported.
Two readouts from the same marrow
Navidinia and colleagues evaluated 109 AML bone marrow samples. Their three-tube flow MRD assay used leukemia-associated phenotypes and deviations from normal maturation. The separate eight-colour tube measured the CD34-positive, CD38-negative, CD45RA-positive population. The gate is an operational phenotype. The study did not directly test self-renewal or demonstrate that cells in the gate can regenerate leukaemia.
The denominator changes what 50 events mean
The investigators required at least 500,000 CD45-positive leukocytes for the MRD analysis and 1.25 million for the stem-cell phenotype. They specified 20 events for detection and 50 for quantification and applied sample-specific quantification limits and distinct positivity cutoffs: 0.1% for MRD and 0.004% for the stem-cell phenotype. At exactly 1.25 million evaluable events, 50 events represent 0.004%. With a different denominator, the same number of events represents a different fraction.

Association within one cohort
The stem-cell phenotype was positive in 28 of 109 samples and conventional flow MRD in 37 of 109. The restricted CD45RA-positive population correlated with MRD at Pearson r = 0.66, compared with r = 0.58 for the broader CD34-positive, CD38-negative population. These are associations between study measurements. They do not establish diagnostic interchangeability or an incremental ability to predict relapse.
Daily Learning Pill
When reporting a rare phenotype, carry the gate definition, number of target events and evaluable denominator together. Verify those properties locally before applying another laboratory’s cutoff.
Read the original study.